Grand Cathay Venture Capital

Grand Cathay Venture Capital (GCVC) is a Taiwan-based venture capital firm that specializes in financing technology-driven enterprises, with a significant focus on the life sciences and biotechnology sectors. Established as the investment arm of Grand Cathay Securities, the firm has historically provided early-stage and growth capital to innovative startups in the Asia-Pacific region. GCVC's portfolio includes notable investments in pharmaceuticals, medical devices, and healthcare services, helping to bridge the gap between scientific research and commercial viability. Following the merger of its parent company with KGI Securities, GCVC became part of the China Development Financial group. The firm is recognized for its role in supporting the growth of Taiwan's biotechnology ecosystem through strategic capital and management expertise.